Get started
Author

Ali İLTER

Observed names: Ali Ilter, Ali İlter
Observed institution: Dokuz Eylül University
ORCID: 0000-0002-6153-7536
Observed ORCID: 0000-0002-6153-7536
OpenAlex ID: A5007271250
Real-World Effects of Finerenone in Diabetics Kidney Disease: Data From Fine-Turk Study
2026 · Serap Yadigar, Suat Akgür, et al. · Research Square · 1
PDF
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry
2026 · Serap Yadigar, Suat Akgür, et al. · Cardiovascular Drugs and Therapy
PDF
Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study
2026 · Serap Yadigar, Suat Akgür, et al. · BMC Nephrology
Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study
2026 · Alper Tuna Güven, Serap Yadigar, et al. · Journal of Clinical Medicine
PDF
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort
2026 · Murat Özdede, Serap Yadigar, et al. · Clinical Kidney Journal
A rare co-existence of celiac disease and C3 glomerulopathy
2025 · Ali Ilter, Meric Oruc, et al. · Nefrología
Pankreasın neoplastik kistlerinde tanı parametreleri: Tek merkez deneyimi
2019 · Ali İLTER, Göksel BENGİ, et al. · Endoskopi Gastrointestinal
PDF
Works count: 7
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type